Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Follistatin fusion proteins and uses thereof

Follistatin fusion proteins and uses thereof

US Patent 9919030 · Granted Mar 20, 2018

Estimated economic value: $20,224,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating vascular eye disorders with ActRII antagonists2022
Methods for treating vascular eye disorders with actrii antagonists2020
Antagonists of activin-ActRIIa and uses for increasing red blood cell levels2018
Activin-actriia antagonists for treating a follicle-stimulating horomone-secreti2016
Antagonists of activin-actriia and uses for increasing red blood cell levels2014
Activin-actriia antagonists for inhibiting germ cell maturation2013
Activin-actrii antagonists and uses for increasing red blood cell levels2011
Activin-ActRII antagonists and uses for increasing red blood cell levels2011
Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion2011
Combination therapy for the treatment of acute leukemia and myelodysplastic synd2010
Treatment of Kaposi's sarcoma with IL-122003
Treatment of Kaposi's sarcoma with IL-122002